Clinical Trial

Oxycodone Versus Sufentanil in Patient-controlled Intravenous Analgesia After Laparoscopic Hysterectomy

Study acronym: Oxycodone
Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated December 4, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study is designed to evaluate the efficacy and safety of hydrocodone in patient-controlled intravenous analgesia (PCIA) during gynecological laparoscopy, thus to explore suitable PCIA scheme to optimize postoperative pain management for patients undergoing gynecological laparoscopic surgeries.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-11-13; most recent amendment 2024-12-02.
Status change: Not Yet Recruiting → Recruiting 2024-12-02
Trial Details
NCT Number NCT06690307
Lead Sponsor Affiliated Hospital of Nantong University
Conditions Laparoscopic Hysterectomy
Enrollment 64 participants
Start Date 2024-12-03
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2024-12-04